FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Dr. Reddy's Amlodipine Besylate and Recall

Dr. Reddy's Amlodipine Besylate and Benazepril Hydrochloride 5 mg*/20 mg, 500 Capsules…

Dr. Reddy's Laboratories, Inc. · Bridgewater, NJ

Risk level
Class II
Reported by FDA
Aug 8, 2012
Recall ID
D-1434-2012
Check your lot numberHow we source this data

Summary

Dr. Reddy's Laboratories recalled Dr. Reddy's Amlodipine Besylate and starting Apr 9, 2012. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1434-2012 on Aug 8, 2012. Reason: Adulterated Presence of Foreign Tablets: Dr. Reddy's Laboratories has received complaints of mislabeled bottles of Amlodipine Besylate and Benazepril Hydrochloride Capsules and Ciprofloxacin Tablets. Status: Terminated.

Why it was recalled

Adulterated Presence of Foreign Tablets: Dr. Reddy's Laboratories has received complaints of mislabeled bottles of Amlodipine Besylate and Benazepril Hydrochloride Capsules and Ciprofloxacin Tablets.

Product description

Dr. Reddy's Amlodipine Besylate and Benazepril Hydrochloride 5 mg*/20 mg, 500 Capsules, Rx only, Mfd. By: Dr. Reddy's Laboratories Limited, Bachepalli - 502 325 INDIA, NDC 55111-340-05

Lot numbers, UPCs & expiration codes

C201293 Exp Date 08/2013

Where it was sold

Nationwide and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1434-2012
Classification
Class II
Status
Terminated
Recall initiated
Apr 9, 2012
FDA report date
Aug 8, 2012
Quantity
1656 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Dr. Reddy's Laboratories, Inc.

Original FDA data

Every field from FDA enforcement report D-1434-2012, exactly as published.

Show all FDA fields
City
Bridgewater
State
NJ
Status
Terminated
Country
United States
Event ID
62591
Address
200 Somerset Corporate Blvd Fl 7th
Code information
C201293 Exp Date 08/2013
Postal code
08807-2862
Report date
Aug 8, 2012
Product type
Drugs
Recall number
D-1434-2012
Classification
Class II
Recalling firm
Dr. Reddy's Laboratories, Inc.
Product quantity
1656 bottles
Termination date
Jan 24, 2013
Reason for recall
Adulterated Presence of Foreign Tablets: Dr. Reddy's Laboratories has received complaints of mislabeled bottles of Amlodipine Besylate and Benazepril Hydrochloride Capsules and Ciprofloxacin Tablets.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Dr. Reddy's Amlodipine Besylate and Benazepril Hydrochloride 5 mg*/20 mg, 500 Capsules, Rx only, Mfd. By: Dr. Reddy's Laboratories Limited, Bachepalli - 502 325 INDIA, NDC 55111-340-05
Distribution pattern
Nationwide and Puerto Rico
Recall initiation date
Apr 9, 2012
Initial firm notification
Letter
Center classification date
Jul 31, 2012

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1434-2012, published Aug 8, 2012. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls